Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
How heart failure risk rises after surgery
Wed June 29th - The development of atrial fibrillation following surgery is an important risk factor for heart failure, researchers report today. More
Brain surgery benefits intracranial pressure
Wed June 29th - Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Researchers hail super-pill success

Thursday July 19th, 2012

Early trials of a proposed super pill to prevent heart disease have come up with promising results, it was announced last night.

Some experts say the pill, known as the Polypill, could be given to everyone over the age of 50.

But the first study has involved just 86 patients. The pill includes a statin to reduce cholesterol and three blood pressure pills.

Participants in the trial include a professor of pharmaceutical policy at University College London, Professor David Taylor.

Researchers at the Wolfson Institute of Preventive Medicine at Barts and The London School of Medicine & Dentistry used a randomised placebo-controlled crossover trial to achieve the highest standards of research over three months.

People who took the genuine pill achieved a 12 per cent cut in blood pressure and a 39 per cent reduction in levels of the unhealthy form of cholesterol, low density lipoprotein - or LDL, the researchers reported in PLoS One.

Researcher Dr David Wald said the findings suggested the pill could give recipients 11 years of life without a heart attack or stroke.

He said: "Our trial shows that the predicted effects of the Polypill can be achieved in practice. The expected impact on preventing what is now the world's leading cause of death is large -- about a two-thirds reduction in heart attacks and strokes."

Professor Taylor said: "The Polypill concept is a major public health advance. This study shows that it works. The Polypill should be made generally available as a matter of urgency.

"I welcome the opportunity to substantially cut my risk of having a stroke or heart attack without the disempowering fuss and bother usually required to obtain preventive medicines."

Professor Nicholas Wald, who originated the Polypill idea, called for political backing for the idea.

He said: "We now need public, professional and regulatory support to make the Polypill available without delay; the net benefits are too large to ignore - even if only 50 percent of people aged 50 or more took the Polypill, about 94,000 heart attacks and stroke would be prevented each year in the UK."

But the British Heart Foundation warned against treating the pill as a miracle cure for unhealthy lifestyles.

Natasha Stewart, of the Foundation, said: “Research into polypills is encouraging, but there are still many questions to answer before this ‘wonder drug’ is prescribed by doctors.

“However interesting this potential new pill is, medicines are not a substitute for living a healthy lifestyle. Staying active, eating healthily and not smoking are still vital ways to help keep your heart in good shape.”

Randomized Polypill crossover trial in people aged 50 and over/" by David Wald, Joan Morris, and Nicholas Wald. PLoS One July 18 2012

Tags: Heart Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)